Pages that link to "Q71609662"
Jump to navigation
Jump to search
The following pages link to The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly (Q71609662):
Displaying 14 items.
- Acromegaly update--etiology, diagnosis and management. (Q34195293) (← links)
- Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization (Q35815975) (← links)
- Dopamine, the dopamine D2 receptor and pituitary tumours (Q37122486) (← links)
- Medical therapy in acromegaly (Q37859250) (← links)
- Gene expression in pituitary adenomas: New insights (Q41636036) (← links)
- Rapid progression of a growth hormone producing tumour during dopamine agonist treatment (Q42090858) (← links)
- Cabergoline therapy of growth hormone & growth hormone/prolactin secreting pituitary tumors (Q42644464) (← links)
- Pegvisomant and cabergoline combination therapy in acromegaly (Q46735065) (← links)
- The growth hormone responses to L-dopa and TRH in acromegaly (Q46944450) (← links)
- Efficacy of combined treatment with lanreotide and cabergoline in selected therapy-resistant acromegalic patients (Q51552603) (← links)
- Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR) for the treatment of acromegaly. (Q53028031) (← links)
- Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acromegalic patients. A double blind placebo-controlled cross-over study (Q58456203) (← links)
- Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas (Q70716815) (← links)
- Recent developments in acromegaly: a review (Q72564541) (← links)